~~<i id='8A5B91E280'><strike id='8A5B91E280'><tt id='8A5B91E280'><pre id='8A5B91E280'></pre></tt></strike></i>~~

Home» Wikipedia» leisure time

leisure time

author：hotspot 2025-09-27 10:52:36 Page View：6

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Welsh Carson private equity firm escapes from FTC antitrust case
Next article： Bright Health sells Medicare Advantage business to Molina

explore

Trump demands the U.S. pay no more for drugs than other countries … again

EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

How a small hospital in rural Puerto Rico survived Hurricane Maria

AfterHurricaneMaria,mostresidentsofruralPuertoRicowerewithoutelectricityandcutofffromhealthcare.InMo

Cancer drug shortages should be causing more outrage

DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

HHS's proposed rule does nothing to address the climate crisis

MariamZuhaib/APInApril,theU.S.DepartmentofHealthandHumanServices,theworld’smostpowerfulhealthcareage